Dld Asset Management, LP Protara Therapeutics, Inc. Transaction History

Dld Asset Management, LP

  • $204 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$2.8 - $5.33 $202,109 - $384,730
-72,182 Reduced 31.45%
157,349 $461,000
Q1 2022

May 13, 2022
BUY
$4.19 - $6.9 $1,257 - $2,070
300 Added 0.13%
229,531 $1.17 Million
Q4 2021

Feb 14, 2022
BUY
$6.15 - $7.76 $1.41 Million - $1.78 Million
229,231 New
229,231 $1.55 Million

Others Institutions Holding TARA

# of Institutions
39
Shares Held
10.7M
Call Options Held
9K
Put Options Held
1.8K
View Full List

About Protara Therapeutics, Inc.

TARA Quotes by TradingView
  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $62.1M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Dld Asset Management, LP Portfolio

Follow Dld Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Dld Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email